Maverix Medical

Maverix Medical is a healthcare company dedicated to improving lung cancer care through innovative diagnostics and medical devices. Backed by Ajax Health, KKR, and Hologic, Inc., the company focuses on enhancing survival rates by enabling earlier and more accurate diagnosis and treatment of lung cancer. Maverix Medical develops a blood-based diagnostic tool, Maverix Dx, aimed at early detection and stratification of lung cancer patients. The company also offers advanced medical devices through its acquisition of Cirrus Bio and Serpex Medical, which provide technologies for precise biopsy targeting and early cancer detection. Additionally, Maverix Medical provides minimally invasive palliative care devices to help manage symptoms and improve the quality of life for patients diagnosed beyond Stage I. The company collaborates with clinicians, healthcare providers, and industry partners to support the full spectrum of lung cancer care, from early detection to intervention and palliative management. With a leadership team experienced in clinical medicine and medical technology, Maverix Medical is committed to advancing lung cancer treatment and patient outcomes.

• Employees 16